In children with type 1 diabetes (T1D), insulin pumps and continuous glucose monitoring (CGM) devices can improve glycemic control, decrease rates of severe hypoglycemia and diabetic ketoacidosis, and reduce risk of microvascular complications [1,2]. This evidence concerns the gene INS and type 1 diabetes mellitus.